Median Time to Antiretroviral Therapy Initiation in a Cohort of Chinese Infants Born With HIV

摘要

A delayed start to antiretroviral therapy (ART) endangers the survival of HIV-infected infants and is a particular concern in resource-limited settings. In China, the health care system has dramatically scaled up its response to HIV, and as of 2012, immediate initiation of ART was recommended for all perinatally infected infants younger than 2 years.1 This study aimed to assess outcomes for infants diagnosed with HIV from 2011 to 2015.